Oyama, Japan

Koji Saito

This inventor holds 5 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1988-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koji Saito. Retrieved from https://idiyas.com/inventor/koji-saito-0ck7s3g3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1988-1994

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Koji Saito

Introduction

Koji Saito is a prominent inventor based in Oyama, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on the development of novel chemical compounds that have potential applications in medicine.

Latest Patents

Among his latest patents are the cyclic aminophenylacetic acid derivatives and the process for preparing them. Additionally, he has developed cyclic anthranilic acid derivatives and the process of preparing the same. These innovations reflect his commitment to advancing pharmaceutical science.

Career Highlights

Koji Saito is currently employed at Kyorin Pharmaceutical Co., Ltd. His role at the company allows him to leverage his expertise in chemistry and innovation to contribute to the development of new therapeutic solutions.

Collaborations

Throughout his career, Saito has collaborated with notable colleagues, including Eisuke Kojima and Yasushi Kohno. These partnerships have fostered a collaborative environment that enhances the creative process in their research endeavors.

Conclusion

Koji Saito's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…